AstraZeneca, Pfizer and more are leveraging the computational power of AI to better design trials, predict the potential ...

But it's not all bad news. A PET scan of a female patient with breast cancer, which has spread to the lymph nodes, bones and liver. In its recent annual report, the American Cancer Society shared ...